The Dominican Society of Rheumatology has proposed to expand the High-Cost Drug Fund to include more diseases requiring specialized treatments. Although the first phase already covers thirteen conditions, the organization emphasizes the importance of gradually assessing the inclusion of other diseases. It also calls for the publication of official statistics on the affected patients and for the improvement of authorization processes for quick access to treatments.